H.R. 9672, Vaccine Compensation Expansion with Tax Increase. Quorum's AI analysis reads it as a trade-off: gains for some, costs for others.
H.R. 9672 · Mixed
What it does
This bill modernizes the federal Vaccine Injury Compensation Program by increasing compensation awards for vaccine-related deaths and injuries (from unspecified baseline to $600,000 each), expanding the program to cover COVID-19 vaccines, adding new vaccines to the injury compensation table, and…
The analysis names vaccine manufacturers (PFE, JNJ, BMY, GH, DVA) via excise tax revenue funding compensation program, — and 2 more groups — among the beneficiaries.
The trade-off
The $2.20 excise tax increase may be passed to consumers, raising vaccine prices and potentially reducing vaccination rates—especially among uninsured and low-income populations—which could undermine public health goals even as the bill expands injury compensation.
The analysis put a high warning level on this bill. Transparency scores 55%; no detached riders.
Who is behind it
Filed by Lloyd Doggett. Cosponsored by Lloyd Smucker.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.